secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K/A
Filed at:   2023-01-23T23:59:59+00:00
Accession:  0001493152-23-002209
Event type: regulatory
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO gets Nasdaq extension until May 22, 2023 to regain compliance with equity rule
--------------------------------------------------------------------------------

- Received Nasdaq deficiency notice on Nov 23, 2022 for stockholders' equity of $1.287M vs $2.5M minimum.
- Submitted compliance plan; Nasdaq granted extension until May 22, 2023 on Jan 18, 2023.
- Must file a publicly available report describing the transaction that enables compliance.
- If not compliant by June 30, 2023 filing, Nasdaq may delist; company can appeal to Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223002209/0001493152-23-002209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223002209/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer